9 nov 2021
CPhI Worldwide 2021

About us

Vectura integrates formulation, device and development capabilities to offer a broad range of services to help customers bring inhaled medicines to market.

Vectura offers comprehensive services from the pre-clinical stage of development, when customers are looking to overcome complex inhaled formulation challenges, select a delivery device and move quickly to the clinic. With expertise in powder and liquid formulations, as well as a portfolio of proprietary device and formulation technologies, Vectura can help customers developing a wide range of small molecules, biologics and complex combinations. 

Optimising drug formulation and delivery device development can unlock the potential for innovative inhaled medicines that can revolutionise patients’ lives. Vectura is at the forefront of integrated drug and device development, and helping customers to deliver the inhaled therapies of the future. 


Specs about this supplier

Sales markets Middle East Region (e.g. UAE); Oceania; North America (USA, Canada); Africa; Central America (e.g. Mexico); East Asia (e.g. China, Japan, Korea); Europe - EU countries; Europe - non EU (e.g. UK, Russia, ex-CIS countries); South America (e.g. Brazil, Colombia); South Asia (e.g. India, Pakistan, Sri Lanka); South East Asia (e.g. Thailand, Philippines, Singapore)
Affiliated categories: Analytical Chemistry |Analytical Development |Analytical Methods More

Products featured at CPhI Worldwide 2021

VECTURA GROUP PLC

Event information

CPhI Worldwide 2021

9-11 November 2021